The development of an antirheumatic drug.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology; D002415:Cats; D002738:Chloroquine / Q000627:therapeutic use; D004285:Dogs; D004890:Erythema / Q000139:chemically induced; D005663:Furans; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009539:Nicotinic Acids; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014456:Ulcer / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D005663:Furans; D007166:Immunosuppressive Agents; D009539:Nicotinic Acids; D006046:Gold; D002738:Chloroquine; D001241:Aspirin